Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson’s Disease via Peroxisome Proliferator-Activated Receptorα

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Neurochemical Research

• Publication date

  2019-01-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11064-018-02705-0PMID 30612307PMCID PMC6450560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of cinnamic acid on memory deficits and brain oxidative stress in streptozotocin-induced diabetic mice

  2018cited by this paper
• Higher serum levels of pro-hepcidin in patients with Parkinson's disease treated with deep brain stimulation.

  2018cited by this paper
• Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications

  2017cited by this paper
• Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study

  2017cited by this paper
• Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson’s Disease

  2017cited by this paper
• Current approaches to the treatment of Parkinson's Disease.

  2017cited by this paper
• PPARα in lysosomal biogenesis: A perspective.

  2016cited by this paper
• Ageing, neurodegeneration and brain rejuvenation

  2016cited by this paper
• Meta-analysis of risk factors for Parkinson’s disease dementia

  2016cited by this paper
• The new definition and diagnostic criteria of Parkinson's disease.

  2016cited by this paper
• Identification and characterization of PPARα ligands in the hippocampus

  2016cited by this paper
• Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease

  2016cited by this paper
• PPARα Signaling in the Hippocampus: Crosstalk Between Fat and Memory

  2015cited by this paper
• Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP

  2015cited by this paper
• HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice.

  2015cited by this paper
• Oxidative stress and Parkinson’s disease

  2015cited by this paper
• Why do patients with Parkinson’s disease fall? A cross-sectional analysis of possible causes of falls

  2015cited by this paper
• Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment.

  2015cited by this paper
• Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists

  2014cited by this paper
• IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples

  2014cited by this paper
• The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging

  2014cited by this paper
• Cinnamon Treatment Upregulates Neuroprotective Proteins Parkin and DJ-1 and Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

  2014cited by this paper
• Protection of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease by a Physically-Modified Saline Containing Charge-Stabilized Nanobubbles

  2014cited by this paper
• Cinnamic Acid Increases Lignin Production and Inhibits Soybean Root Growth

  2013cited by this paper
• Role of Oxidative Stress in Parkinson's Disease

  2013cited by this paper
• The Role of Oxidative Stress in Parkinson's Disease

  2013cited by this paper
• Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system.

  2013cited by this paper
• Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor α.

  2013cited by this paper
• The current and projected economic burden of Parkinson's disease in the United States

  2013cited by this paper
• Quality of life in Parkinson`s Disease

  2012cited by this paper
• Parkinson's disease.

  2012cited by this paper
• Simple In Vitro Assays to Identify Amyloid-β Aggregation Blockers for Alzheimer's Disease Therapy

  2010cited by this paper
• Ageing, neurodegeneration and Parkinson's disease.

  2010cited by this paper
• Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.

  2009cited by this paper
• Gemfibrozil, stretching arms beyond lipid lowering

  2009cited by this paper
• Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

  2009cited by this paper
• Hallucinations in Parkinson disease

  2009cited by this paper
• Integration of metabolism and inflammation by lipid-activated nuclear receptors

  2008cited by this paper
• Emerging Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in the Regulation of Neural Stem Cells Proliferation and Differentiation

  2008cited by this paper
• PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis

  2008cited by this paper
• Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

  2007cited by this paper
• Peroxisome proliferator‐activated receptor‐alpha is required for the neurotrophic effect of oleic acid in neurons

  2007cited by this paper
• Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.

  2007cited by this paper
• Protocol for the MPTP mouse model of Parkinson's disease

  2007cited by this paper
• The dependence of serum interleukin-6 level on PPAR-alpha polymorphism in men with coronary atherosclerosis.

  2005cited by this paper
• PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats.

  2004cited by this paper
• Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

  2004cited by this paper
• PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

  2004cited by this paper
• Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Agonists for Neurological Disease

  2003cited by this paper
• Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

  2003cited by this paper
• Gemfibrozil, a Lipid-lowering Drug, Inhibits the Induction of Nitric-oxide Synthase in Human Astrocytes*

  2002cited by this paper
• A Population-Based Case-Control Study of Farming and Breast Cancer in North Carolina

  2000cited by this paper
• Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.

  1999cited by this paper
• Role of Oxidative Stress In Parkinsons Disease

  1999cited by this paper
• Cinnamic acid: A natural product with potential use in cancer intervention

  1995cited by this paper
• The RXR heterodimers and orphan receptors.

  1995cited by this paper
• Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease

  1995cited by this paper

• Ethanol-Precipitated Saccharides: Essential for Danggui Sini Decoction Against Oxaliplatin-Induced Neurotoxicity.

  2026cites this paper
• Saliva as a non-invasive matrix for assessing xenobiotic metabolites and metabolomes: implications for maternal health and preeclampsia

  2025cites this paper
• Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects

  2025cites this paper
• Metabolomic profiling uncovers diagnostic biomarkers and dysregulated pathways in Parkinson’s disease

  2025cites this paper
• Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.

  2025cites this paper
• Surface moieties drive the superior protection of curcumin-derived carbon quantum dots against retinal ischemia-reperfusion injury.

  2025cites this paper
• Cinnamic acid alleviates endothelial dysfunction and oxidative stress by targeting PPARδ in obesity and diabetes

  2025cites this paper
• Cinnamic acid prevents skeletal muscle atrophy in nephrectomized rats by modulating apoptosis and endoplasmic reticulum stress.

  2025cites this paper
• Formulation, Evaluation and Acute Oral Toxicity Study of Polyherbal Syrup TCZoAP

  2025cites this paper
• Exploring the Mechanism of Cinnamomi ramulus in Treating Chronic Atrophic Gastritis Rats Based on Metabolomics and 16S rRNA Sequencing

  2025cites this paper
• Enrichment of gut-derived metabolites in a Parkinson’s disease subtype with REM sleep behavior disorder

  2025cites this paper
• Cinnamic acid, a natural plant compound, exhibits neuroprotection in a mouse model of Sandhoff disease via PPARα

  2024cites this paper
• Impact of natural compounds on peroxisome proliferator-activated receptor: Molecular effects and its importance as a novel therapeutic target for neurological disorders.

  2024cites this paper
• Study of Host-Guest Interaction and In Vitro Neuroprotective Potential of Cinnamic Acid/Randomly Methylated β-Cyclodextrin Inclusion Complex

  2024cites this paper
• Nerolidol- Potential Therapeutic Agent for Various Neurological Disorders via its Antioxidative Property.

  2024cites this paper
• Integrative transcriptome-proteome approach reveals key hypoxia-related features involved in the neuroprotective effects of Yang Xue oral liquid on Alzheimer’s and Parkinson’s disease

  2024cites this paper
• Mesenchymal stem cell‐derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs

  2023cites this paper
• Extraction of bioactive compounds from cinnamon residues with deep eutectic solvents and its molecular mechanism

  2023cites this paper
• Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization

  2023cites this paper
• Pasture-finishing of bison improves animal metabolic health and potential health-promoting compounds in meat

  2023cites this paper
• Synthesis, Molecular Docking, and Neuroprotective Effect of 2-Methylcinnamic Acid Amide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—An Induced Parkinson’s Disease Model

  2022cites this paper
• Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway.

  2022cites this paper
• Cinnamic Acid Improved Lipopolysaccharide-Induced Depressive-Like Behaviors by Inhibiting Neuroinflammation and Oxidative Stress in Mice

  2022cites this paper
• The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity.

  2022cites this paper
• Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols

  2022cites this paper
• Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases

  2022cites this paper
• Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments

  2022cites this paper
• Omics combined with network pharmacology reveal the neuroprotective mechanism of Sophora tonkinensis based on the biolabel research pattern: The treatment of Parkinson's disease against oxidative stress and neuroexcitatory toxicity.

  2022cites this paper
• Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway

  2021cites this paper
• Bilirubin: A Ligand of the PPARα Nuclear Receptor

  2021cites this paper
• Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides

  2021cites this paper
• Overview of Beneficial Effects of (Poly)phenol Metabolites in the Context of Neurodegenerative Diseases on Model Organisms

  2021cites this paper
• A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson’s disease

  2021cites this paper
• Cinnamic acid ameliorate gentamicin-induced liver dysfunctions and nephrotoxicity in rats through induction of antioxidant activities

  2021cites this paper
• Cinnamic acid inhibits Zika virus by inhibiting RdRp activity.

  2021cites this paper
• The neuroprotective effects of isoquercitrin purified from apple pomace by high-speed countercurrent chromatography in the MPTP acute mouse model of Parkinson's disease.

  2021cites this paper
• Pharmacogenetic‐based management of depression: Role of traditional Persian medicine

  2021cites this paper
• Neuroprotective expression of turmeric and curcumin

  2020cites this paper
• Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model

  2020cites this paper
• Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2.

  2019cites this paper
• Coumaric and Cinnamic Acids in Food

  2019cites this paper
• The traditional uses, phytochemistry, pharmacology and toxicology of Cinnamomi ramulus: a review

  2019cites this paper
• RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.

  2019cites this paper